![Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance | Prostate Cancer and Prostatic Diseases Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41391-019-0167-9/MediaObjects/41391_2019_167_Fig1_HTML.png)
Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance | Prostate Cancer and Prostatic Diseases
Society of Urologic Oncology - A PROSTATE BIOPSY RISK CALCULATOR BASED ON MAGNETIC RESONANCE IMAGING: DEVELOPMENT AND COMPARISON TO THE PBCG RISK CALCULATOR
![Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators - European Urology Focus Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/asset/a9ff3c6d-b2c8-4218-97ab-9d8b49da6cee/gr1.jpg)
Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators - European Urology Focus
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283812008342-gr2.jpg)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect
Indonesian Prostate Cancer Risk Calculator (IPCRC): An application for Predicting Prostate Cancer Risk (a Multicenter Study)
![CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2011/06/capra-s-rev.png)
CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK
![Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS) | SpringerLink Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00345-017-2150-1/MediaObjects/345_2017_2150_Fig2_HTML.gif)
Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS) | SpringerLink
![IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies](https://www.mdpi.com/ijms/ijms-24-02449/article_deploy/html/images/ijms-24-02449-g001.png)
IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies
![Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice](https://bjgp.org/content/bjgp/71/706/e364/F1.large.jpg)
Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice
![A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-019-0553-6/MediaObjects/12894_2019_553_Fig1_HTML.png)
A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/34fd32696f2b1472725b338fc204d29585f2fe93/5-Figure2-1.png)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar
![Prostate Cancer Risk Calculator Goes Through an Update to Improve Users' Understanding of the Disease Prostate Cancer Risk Calculator Goes Through an Update to Improve Users' Understanding of the Disease](https://images.medindia.net/amp-images/health-images/screening-prostate-cancer.jpg)